CAS 20439-47-8

(1R,2R)-cyclohexane-1,2-diamine

Codes: MIRI-005

Application context (from source-drug indications)

Hepatocellular carcinomaMiriplatin Hydrate

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Miriplatin Hydrate	Tier C — Watch / trade	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Miriplatin HydrateOptimised routesteps: 2total yield: /

(1R,2R)-cyclohexane-1,2-diamine→MIRI-006→(tetradecanoyloxy)silver

Miriplatin HydrateProcess routesteps: 3total yield: 12.6 g

sodium tetradecanoate→(1R,2R)-cyclohexane-1,2-diamine→MIRI-008→MIRI-009

Miriplatin HydrateProcess routesteps: 3total yield: 13.2 g

sodium tetradecanoate→(1R,2R)-cyclohexane-1,2-diamine→MIRI-010

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.